Max Healthcare Board to Consider Financial Results on February 5, 2026

The Board of Directors of Max Healthcare Institute Limited is scheduled to meet on Thursday, February 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The trading window remains closed for designated persons until 48 hours after the declaration of the financial results.

Board Meeting Announcement

Max Healthcare Institute Limited has announced that a meeting of its Board of Directors is scheduled for February 5, 2026. The primary purpose of this meeting is to review and approve the unaudited standalone and consolidated financial results of the company.

Financial Results Focus

The financial results under consideration will be for the quarter and nine months which concluded on December 31, 2025. Once approved, these results will provide investors and stakeholders with an overview of Max Healthcare’s financial performance.

Trading Window Closure

In accordance with company policy, the trading window for dealing in the company’s securities remains closed for all designated persons and their immediate relatives. This restriction will be lifted 48 hours after the official declaration of the financial results. This measure ensures compliance and prevents any potential misuse of insider information during the sensitive period leading up to the results announcement.

Disclosure Availability

The company stated that the financial results will be available on the company’s website: www.maxhealthcare.in following their approval by the board.

Source: BSE

Previous Article

LT Foods Board Approves Interim Dividend and Internal Auditor Changes

Next Article

Lodha Reports Strong Q3 FY26 Performance, Investor Presentation